<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">METHOHEXITAL SODIUM</span><br/>(meth-oh-hex'i-tal)<br/><span class="topboxtradename">Brevital Sodium<br/></span><b>Classifications:</b> <span class="classification">central nervous system (cns) agent</span>; <span class="classification">general anesthetic</span>; <span class="classification">barbiturate</span><br/><b>Prototype: </b>Thiopental<br/><b>Pregnancy Category: </b>B<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>500 mg, 2.5 g, 5 g powder for injection</p>
<h1><a name="action">Actions</a></h1>
<p>Rapid, ultra-short-acting barbiturate anesthetic agent. More potent than thiopental but has less cumulative effect and shorter
         duration of action, and recovery is more rapid.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Induces brief general anesthesia without analgesia by depression of the CNS.</p>
<h1><a name="uses">Uses</a></h1>
<p>Induction of anesthesia, as supplement for other anesthetics, and as general anesthetic for brief operative procedures.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to methohexital sodium; agranulocytosis; barbiturate hypersensitivity; hepatic encephalopathy; intraarterial
         administration; shock, heart failure, PVD, severe hypo- and hypertension, respiratory depression, infants 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category B), labor, lactation; adrenal insufficiency, anemia, carbamazepine hypersensitivity; cardiac disease,
         COPD; uncontrolled asthma, status asthmaticus, sleep apnea, respiratory insufficiency, CNS depression; depression, ethanol
         intoxication; exfoliative dermatitis; hepatic disease; hydantoin hypersensitivity, older adult; neuromuscular disease; obesity;
         porphyria; pulmonary disease, renal disease, uremia, renal impairment; seizure disorders, status epilepticus, seizures; shock.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Induction of Anesthesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 512 mL of 1% solution (50120 mg) at a rate of 1 mL (5 mg) q5min, then 24 mL (2040 mg) q47min
               prn<br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> 12 mg/kg <span class="rdroute">PR</span> 2035 mg/kg as 10% solution (max: 500 mg/dose)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><ul>
<li>Give to recumbent patient. Fall in BP may occur in susceptible patients receiving drug in upright position.</li>
</ul>
<p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span> Prepare a 1% solution (10 mg/mL) by diluting with sterile water for injection, D5W, or NS. Use only clear, colorless solutions.
                  Do not allow contact with rubber stoppers or parts of syringes treated with silicone because solution is incompatible with
                  acid solutions (see <small>IMCOMPATIBILITIES</small>).  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Give 5 mg over 510 sec.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span> <b>Atropine,</b> <b>chlorpromazine,</b> <b>clindamycin,</b> <b>fentanyl,</b> <b>glycopyrrolate,</b> <b>hydralazine,</b> <b>kanamycin,</b> <b>lidocaine,</b> <b>methicillin,</b> <b>mechlorethamine,</b> <b>methyldopa,</b> <b>pentazocine,</b> <b>prochlorperazine,</b> <b>promazine,</b> <b>promethazine,</b> <b>streptomycin,</b> <span class="classification">tetracyclines</span>. 
               </p>
</td>
</tr>
</table>
<ul>
<li>Store drug in sterile water for injection at room temperature for at least 6 wk. Solutions prepared with isotonic NaCl injection
            or 5% dextrose injection are stable for <b><small>ONLY</small></b> about 24 h.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> CV:</span> Hypotension, cardiac arrhythmias, cardiac arrest. <span class="typehead">Musculoskeletal:</span> Muscle spasm. <span class="typehead">CNS:</span> Postoperative psychomotor impairment that persists for 24 hours, anxiety, drowsiness, emergence delirium, restlessness, and
      seizures. <span class="typehead">Respiratory:</span> Bronchospasm, cough, hiccups, respiratory depression, apnea, dyspnea, <span class="speceff-life">respiratory arrest</span>. <span class="typehead">Skin:</span> Phlebitis and nerve injury adjacent to the injection site, local irritation, edema, ulceration, necrosis. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol</b> and other <span class="classification">cns depressants</span> enhance CNS depression. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 17% absorbed PR. <span class="typehead">Distribution:</span> Crosses CNS, placenta and excreted in breast milk. <span class="typehead">Metabolism:</span> Oxidized in liver. <span class="typehead">Elimination:</span> Primarily excreted in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Hiccups are common, particularly with rapid injection; they sometimes persist after anesthesia.</li>
<li>Keep facilities for assisting respiration and administration of oxygen readily available in the event of respiratory distress.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>